Viridian Therapeutics (VRDN) was a big mover on higher-than-average trading volume in the latest session. A recent trend of downward earnings estimate revisions may act as a near-term headwind and limit the stock's ability to continue moving higher.
Viridian Therapeutics (VRDN) was a big mover on higher-than-average trading volume in the latest session. A recent trend of downward earnings estimate revisions may act as a near-term headwind and limit the stock's ability to continue moving higher.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
